140 related articles for article (PubMed ID: 26245909)
1. Antitumour effects of tetrazanbigen against human hepatocellular carcinoma QGY-7701 through inducing lipid accumulation in vitro and in vivo.
Zheng X; Li W; Lan Z; Yang X; Li L; Yuan Y; Xia Z; Chen X; Zhang X; Yu Y
J Pharm Pharmacol; 2015 Nov; 67(11):1593-602. PubMed ID: 26245909
[TBL] [Abstract][Full Text] [Related]
2. TNBG-5602, a novel derivative of quinoxaline, inhibits liver cancer growth via upregulating peroxisome proliferator-activated receptor γ in vitro and in vivo.
Hu X; Wan C; Gan Z; Liu R; Chen Y; Wang J; Gan L; Chen Y; Li Y; He B; Yu Y
J Pharm Pharmacol; 2019 Nov; 71(11):1684-1694. PubMed ID: 31446646
[TBL] [Abstract][Full Text] [Related]
3. Effects of tetrazanbigen on the protein expression in human hepatocellular carcinoma cell line QGY-7701.
Yuan Y; Li W; Li L; Yang X; Gu R; Liu H; Huang K; Yu Y
J Huazhong Univ Sci Technolog Med Sci; 2009 Jun; 29(3):304-8. PubMed ID: 19513611
[TBL] [Abstract][Full Text] [Related]
4. [Effects of TNBG on the proliferation and apoptosis of human hepatocellular carcinoma cell line QGY-7701].
Li LJ; Yu Y; Tang WX; Chen ZQ; Yuan YH; Yang XL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 May; 36(3):372-4. PubMed ID: 15931872
[TBL] [Abstract][Full Text] [Related]
5. Tetrazanbigen Derivatives as Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Partial Agonists: Design, Synthesis, Structure-Activity Relationship, and Anticancer Activities.
Gan L; Gan Z; Dan Y; Li Y; Zhang P; Chen S; Ye Z; Pan T; Wan C; Hu X; Yu Y
J Med Chem; 2021 Jan; 64(2):1018-1036. PubMed ID: 33423463
[TBL] [Abstract][Full Text] [Related]
6. Anticancer activity and mechanisms of diacetyldianhydrogalactitol on hepatoma QGY-7703 cells.
Zhang XY; Lian Yan X; Guo W; Xu B; Li M; Zhou Y; Rong Cui J
Anticancer Drugs; 2009 Nov; 20(10):926-31. PubMed ID: 19741503
[TBL] [Abstract][Full Text] [Related]
7. BND-12, a novel nonhaematotoxic naphthalimide derivative, inhibits tumour growth and metastasis of hepatocellular carcinoma.
Xie SQ; Li Q; Zhang YH; Li Z; Zhao J; Wang CJ
J Pharm Pharmacol; 2012 Oct; 64(10):1483-90. PubMed ID: 22943179
[TBL] [Abstract][Full Text] [Related]
8. SC-III3, a novel scopoletin derivative, induces cytotoxicity in hepatocellular cancer cells through oxidative DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activation.
Zhao P; Chen L; Li LH; Wei ZF; Tong B; Jia YG; Kong LY; Xia YF; Dai Y
BMC Cancer; 2014 Dec; 14():987. PubMed ID: 25527123
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of acriflavine in human hepatocellular carcinoma cells.
Lee CJ; Yue CH; Lin YY; Wu JC; Liu JY
Anticancer Res; 2014 Jul; 34(7):3549-56. PubMed ID: 24982368
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo anticancer activity evaluation of ursolic acid derivatives.
Shao JW; Dai YC; Xue JP; Wang JC; Lin FP; Guo YH
Eur J Med Chem; 2011 Jul; 46(7):2652-61. PubMed ID: 21514015
[TBL] [Abstract][Full Text] [Related]
11. Antitumour effects of a protease inhibitor, nelfinavir, in hepatocellular carcinoma cancer cells.
Sun L; Niu L; Zhu X; Hao J; Wang P; Wang H
J Chemother; 2012 Jun; 24(3):161-6. PubMed ID: 22759761
[TBL] [Abstract][Full Text] [Related]
12. Ethyl pyruvate inhibits proliferation and induces apoptosis of hepatocellular carcinoma via regulation of the HMGB1-RAGE and AKT pathways.
Cheng P; Dai W; Wang F; Lu J; Shen M; Chen K; Li J; Zhang Y; Wang C; Yang J; Zhu R; Zhang H; Zheng Y; Guo CY; Xu L
Biochem Biophys Res Commun; 2014 Jan; 443(4):1162-8. PubMed ID: 24361892
[TBL] [Abstract][Full Text] [Related]
13. Total alkaloids of Rubus aleaefolius Poir inhibit hepatocellular carcinoma growth in vivo and in vitro via activation of mitochondrial-dependent apoptosis.
Zhao J; Chen X; Lin W; Wu G; Zhuang Q; Zhong X; Hong Z; Peng J
Int J Oncol; 2013 Mar; 42(3):971-8. PubMed ID: 23338043
[TBL] [Abstract][Full Text] [Related]
14. Mannose-mediated inhibitory effects of PA-MSHA on invasion and metastasis of hepatocellular carcinoma via EGFR/Akt/IκBβ/NF-κB pathway.
Li T; Dong ZR; Guo ZY; Wang CH; Zhi XT; Zhou JW; Li DK; Chen ZT; Chen ZQ; Hu SY
Liver Int; 2015 Apr; 35(4):1416-29. PubMed ID: 25066210
[TBL] [Abstract][Full Text] [Related]
15. Both antiangiogenesis- and angiogenesis-independent effects are responsible for hepatocellular carcinoma growth arrest by tyrosine kinase inhibitor PTK787/ZK222584.
Liu Y; Poon RT; Li Q; Kok TW; Lau C; Fan ST
Cancer Res; 2005 May; 65(9):3691-9. PubMed ID: 15867364
[TBL] [Abstract][Full Text] [Related]
16. Sprengerinin C exerts anti-tumorigenic effects in hepatocellular carcinoma via inhibition of proliferation and angiogenesis and induction of apoptosis.
Zeng KW; Li N; Dong X; Ma ZZ; Jiang Y; Jin HW; Tu PF
Eur J Pharmacol; 2013 Aug; 714(1-3):261-73. PubMed ID: 23684542
[TBL] [Abstract][Full Text] [Related]
17. Characterization of 9-nitrocamptothecin liposomes: anticancer properties and mechanisms on hepatocellular carcinoma in vitro and in vivo.
Zheng S; Chang S; Lu J; Chen Z; Xie L; Nie Y; He B; Zou S; Gu Z
PLoS One; 2011; 6(6):e21064. PubMed ID: 21695227
[TBL] [Abstract][Full Text] [Related]
18. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of phenyl substituted polyoxygenated xanthone derivatives as anti-hepatoma agents.
Dai M; Yuan X; Kang J; Zhu ZJ; Yue RC; Yuan H; Chen BY; Zhang WD; Liu RH; Sun QY
Eur J Med Chem; 2013 Nov; 69():159-66. PubMed ID: 24013415
[TBL] [Abstract][Full Text] [Related]
20. Saffron inhibits the proliferation of hepatocellular carcinoma via inducing cell apoptosis.
Liu T; Tian L; Fu X; Wei L; Li J; Wang T
Panminerva Med; 2020 Mar; 62(1):7-12. PubMed ID: 30657284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
